Anaplastic Large Cell Lymphoma Symptoms

Anaplastic Large Cell Lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma, a cancer that starts in white blood cells called lymphocytes. The symptoms of ALCL can vary depending on where the cancer begins. Common signs often include swollen lymph nodes, fever, night sweats, and unexplained weight loss, but skin changes can also occur.

What is Anaplastic Large Cell Lymphoma Symptoms?

Anaplastic Large Cell Lymphoma (ALCL) is a type of cancer that affects specific white blood cells called T-lymphocytes, which are part of your immune system. Symptoms arise when these abnormal cells grow and accumulate, often leading to swollen lymph nodes or skin lesions. The specific symptoms you experience depend on the type of ALCL and where it develops in your body.

ALCL is considered a rare form of non-Hodgkin lymphoma. Lymphoma is a cancer that begins in the lymphatic system, a network of tissues and organs that help rid the body of toxins, waste, and other unwanted materials. The lymphatic system includes the lymph nodes, spleen, thymus, and bone marrow. There are two main types of ALCL: systemic ALCL and primary cutaneous ALCL. Systemic ALCL affects lymph nodes and can spread to other organs, while primary cutaneous ALCL mainly affects the skin. Understanding the type helps predict the likely symptoms and how the disease might progress. Symptoms are the body's way of signaling that something is wrong. In ALCL, these signals are caused by the uncontrolled growth of abnormal T-lymphocytes. These cells can form tumors or cause inflammation, leading to the various signs and symptoms you might notice.

Symptoms

The symptoms of Anaplastic Large Cell Lymphoma (ALCL) can vary significantly between individuals and depend on whether the lymphoma is systemic or primarily affects the skin. Common signs include enlarged lymph nodes, fever, night sweats, and unexplained weight loss. Other symptoms might involve skin rashes or fatigue, reflecting the body's response to the cancer.

For systemic ALCL, the most common symptom is the development of swollen, usually painless, lymph nodes (lymphadenopathy). These enlarged nodes can often be felt in the neck, armpit, or groin. The swelling occurs because the cancerous T-lymphocytes accumulate within these nodes. Many people with systemic ALCL also experience a group of general symptoms known as B symptoms. These include fevers that come and go without infection, drenching night sweats that soak clothing and bedding, and unexplained weight loss of more than 10% of your body weight over six months. These B symptoms are common in many lymphomas and indicate that the cancer is active. Other symptoms of systemic ALCL can include fatigue, loss of appetite, and sometimes skin rashes or lumps. If the lymphoma spreads to other organs, such as the bones, liver, or lungs, it can cause pain, shortness of breath, or other specific issues related to those organs. Primary cutaneous ALCL, on the other hand, mainly presents as skin lesions, which can be red or purplish bumps (nodules) or patches that may sometimes break open (ulcerate). These skin lesions are often the first and only sign of this type of ALCL, and B symptoms are much less common.

Causes & risk factors

Anaplastic Large Cell Lymphoma (ALCL) occurs when T-lymphocytes, a type of white blood cell, develop genetic changes that cause them to grow abnormally. While the exact reason these changes happen is not fully understood, ALCL is not typically inherited. Risk factors are not well-defined, but certain conditions or age groups may have a slightly higher chance of developing it.

The primary cause of ALCL is a change, or mutation, in the genes of T-lymphocytes. In many cases of systemic ALCL, this involves a specific genetic rearrangement called the ALK (anaplastic lymphoma kinase) gene translocation. This change leads to the production of an abnormal protein that promotes uncontrolled cell growth. These genetic changes are acquired during a person's lifetime and are not usually passed down from parents to children. Unlike some other cancers, there are no clearly established lifestyle-related risk factors for ALCL, such as smoking or diet. It is a relatively rare cancer, and most people who develop it do not have a clear reason why. Researchers continue to study the underlying mechanisms to better understand why these genetic changes occur. While specific risk factors are not well-defined, ALCL can affect people of all ages. Systemic ALCL tends to be more common in children and young adults, as well as older adults. Primary cutaneous ALCL typically affects older adults. Some studies suggest that individuals with certain immune system disorders or those who have received organ transplants and are on immunosuppressive medications might have a slightly increased risk, but this link is not definitively established for all types of ALCL.

How it's diagnosed

Diagnosing Anaplastic Large Cell Lymphoma (ALCL) typically begins with a physical exam and a review of your symptoms. The definitive diagnosis requires a biopsy, where a small tissue sample from a swollen lymph node or skin lesion is removed and examined under a microscope. Further tests, such as imaging scans and blood tests, help determine the extent of the lymphoma.

If you have symptoms suggestive of ALCL, your doctor will perform a physical examination, checking for swollen lymph nodes, skin abnormalities, and other signs. They will also ask about your medical history and the duration and nature of your symptoms. This initial assessment helps guide the diagnostic process. The most crucial step for diagnosis is a biopsy. This involves surgically removing a small piece of the affected tissue, such as an enlarged lymph node or a skin lesion. A pathologist, a doctor who specializes in examining tissues, will then analyze the sample under a microscope to identify the characteristic features of ALCL cells. Special tests on the biopsy sample, like immunohistochemistry and genetic testing, are used to confirm the diagnosis and identify specific genetic markers, such as the ALK gene rearrangement, which is important for treatment planning. Once ALCL is confirmed, further tests are done to determine the stage of the lymphoma, meaning how far it has spread. These staging tests may include imaging scans like computed tomography (CT) scans, positron emission tomography (PET) scans, or magnetic resonance imaging (MRI) scans to look for lymphoma in other parts of the body. A bone marrow biopsy, where a small sample of bone marrow is taken, may also be performed to check if the lymphoma has spread to the bone marrow. Blood tests are also conducted to assess your overall health and organ function.

Treatment options

Treatment for Anaplastic Large Cell Lymphoma (ALCL) depends on the type, stage, and specific genetic features of the lymphoma. For systemic ALCL, chemotherapy is the primary treatment, often combined with targeted therapies that specifically attack cancer cells with certain genetic markers. Primary cutaneous ALCL may be treated with less intensive methods like surgery or radiation, as it often has a more localized course.

For systemic ALCL, chemotherapy is the cornerstone of treatment. This involves using powerful drugs to kill rapidly growing cancer cells throughout the body. The specific chemotherapy regimen will be chosen by your medical team based on factors like your age, overall health, and the specific characteristics of your lymphoma. In cases where the ALK gene rearrangement is present, targeted therapies that specifically block the ALK protein can be very effective, often used in combination with or after chemotherapy. Radiation therapy, which uses high-energy rays to kill cancer cells, may be used for localized areas of lymphoma or in specific situations. For some individuals, especially those with recurrent or aggressive systemic ALCL, a stem cell transplant (either using your own cells, autologous, or donor cells, allogeneic) might be considered. This intensive treatment aims to replace diseased bone marrow with healthy stem cells. Primary cutaneous ALCL, which is generally less aggressive and often confined to the skin, typically requires less intensive treatment. Options may include surgical removal of the skin lesions, radiation therapy directed at the affected skin, or topical treatments applied directly to the skin. In some cases, if the skin lesions are widespread or persistent, systemic treatments like chemotherapy or targeted therapy might be considered, but this is less common than for systemic ALCL.

Recovery & outlook

The recovery and outlook for Anaplastic Large Cell Lymphoma (ALCL) vary significantly depending on the type of lymphoma and its specific genetic features. Systemic ALCL, particularly the ALK-positive type, generally has a good prognosis with high rates of remission, especially in children and young adults. Primary cutaneous ALCL typically has an excellent outlook, often remaining localized to the skin. Regular follow-up care is crucial for all types.

For systemic ALCL, the presence of the ALK gene rearrangement (ALK-positive ALCL) is a key factor in prognosis. ALK-positive ALCL generally responds very well to treatment, and many people achieve long-term remission, meaning the signs and symptoms of cancer disappear. The outlook for ALK-negative systemic ALCL can be more variable, and it may be more challenging to treat, sometimes requiring more intensive therapies. Children and young adults with systemic ALCL often have a very favorable prognosis. However, recurrence, where the cancer returns after treatment, is possible for both ALK-positive and ALK-negative types. Therefore, ongoing monitoring and follow-up appointments with your healthcare team are essential to detect any signs of recurrence early. Primary cutaneous ALCL typically has an excellent prognosis. It is often a slow-growing lymphoma that usually stays confined to the skin and rarely spreads to other parts of the body. While skin lesions may recur, they are often manageable with local treatments. Your doctor will discuss your specific prognosis based on your individual diagnosis, treatment response, and any genetic markers identified in your lymphoma.

When to see a doctor

You should see a doctor if you notice any persistent or concerning symptoms that could indicate Anaplastic Large Cell Lymphoma (ALCL). This includes unexplained swollen lymph nodes that do not go away, persistent fevers, drenching night sweats, or unexplained weight loss. New or changing skin lumps or rashes that do not resolve should also prompt a medical evaluation to determine the cause.

It is important to remember that many of the symptoms of ALCL, such as swollen lymph nodes or fever, can be caused by much more common and less serious conditions, like infections. However, if these symptoms are persistent, worsen over time, or occur without an obvious cause, it is crucial to seek medical advice. Early diagnosis can lead to more effective treatment. Specifically, you should contact your doctor if you experience any of the following: swollen lymph nodes that are painless and do not shrink after a few weeks; unexplained fevers that last for several days or weeks; drenching night sweats that are not related to your environment; or significant, unintentional weight loss. These are often referred to as B symptoms and warrant prompt investigation. Additionally, if you develop new skin lumps, nodules, or rashes that persist, grow, or change in appearance, especially if they are not itchy or painful, you should have them checked by a healthcare professional. While these could be benign, they are a key symptom of primary cutaneous ALCL. Always discuss any new or concerning symptoms with a qualified clinician to get an accurate diagnosis and appropriate guidance.

Frequently asked questions

Is Anaplastic Large Cell Lymphoma (ALCL) a common cancer?

No, Anaplastic Large Cell Lymphoma (ALCL) is considered a rare type of non-Hodgkin lymphoma. It accounts for a small percentage of all lymphoma cases, though it can affect both children and adults.

Are the swollen lymph nodes from ALCL usually painful?

Typically, the swollen lymph nodes (lymphadenopathy) associated with Anaplastic Large Cell Lymphoma (ALCL) are painless. However, their size can sometimes cause discomfort or pressure on surrounding tissues.

Can ALCL be cured?

For many people, Anaplastic Large Cell Lymphoma (ALCL) can be effectively treated, and many achieve long-term remission, especially the ALK-positive systemic type and primary cutaneous ALCL. The term 'cure' is used cautiously in cancer, but the prognosis is often favorable.

What is the difference between systemic and primary cutaneous ALCL?

Systemic ALCL primarily affects lymph nodes and can spread to other organs, often causing general symptoms like fever and weight loss. Primary cutaneous ALCL mainly affects the skin, causing lesions, and usually remains localized without spreading widely.

Are there specific genetic tests for ALCL?

Yes, genetic testing on a biopsy sample is crucial for diagnosing Anaplastic Large Cell Lymphoma (ALCL). It can identify specific genetic changes, such as the ALK gene rearrangement, which helps confirm the diagnosis and guides treatment decisions.

If I have swollen lymph nodes, does that mean I have ALCL?

No, swollen lymph nodes are a very common symptom caused by many conditions, most often infections like the common cold or strep throat. While swollen lymph nodes can be a symptom of ALCL, they are far more likely to be due to a benign cause. You should see a doctor if the swelling is persistent, painless, or accompanied by other concerning symptoms.

Sources

• MedlinePlus — Anaplastic Large Cell Lymphoma Symptoms
• Mayo Clinic — Anaplastic Large Cell Lymphoma Symptoms
• Cochrane Library — Anaplastic Large Cell Lymphoma Symptoms